Publication | Closed Access

Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

InflammationChronic Inflammatory DiseasesTumor Necrosis FactorAnti-inflammatoryMucosal ImmunologyImmunologyChronic InflammationPathologyImmune-mediated Inflammatory DiseasesMedicineInflammatory Disease